The Relationship Between Medication Adherence Based on the Morisky Medication Adherence Scale 8 (MMAS-8) and the Degree of Disease Activity Based on the Disease Activity Score-28 (DAS28) in Rheumatoid Arthritis Patients at Royal Prima Hospital
DOI:
https://doi.org/10.51601/ijhp.v5i4.503Abstract
Rheumatoid arthritis (RA) poses a major health challenge due to poor medication adherence impacting disease control. This study aimed to analyze the relationship between medication adherence (MMAS-8) and disease activity (DAS28) in RA patients. A quantitative cross-sectional design was employed at RS Royal Prima Medan (May-July 2025), targeting outpatient RA patients with consecutive sampling (n=69). Data were collected using validated MMAS-8 and DAS28-CRP instruments, analyzed via Kolmogorov-Smirnov normality tests and Spearman's correlation. Results showed moderate adherence (47.8%), low disease activity predominant (31.9%), and significant moderate positive correlation (r=0.400, p<0.001). Higher adherence is linked to better disease control. Conclusion: Medication adherence moderately influences RA disease activity; multifaceted interventions are recommended.
Downloads
References
Achmad, A., Putra Suryana, B., & Rahmayanti, TY (2020). The relationship between methotrexate therapy adherence and Disease Activity Score 28 (DAS28) in rheumatoid arthritis patients. Pharmaceutical Journal of Indonesia, 5(2), 103–107.https://doi.org/10.21776/ub.pji.2020.005.02.6
Albiss, B.A., Abu-Zeid, Y.A., & Althubiani, E.S. (2025). Prevalence of obesity and its impact on disease activity in rheumatoid arthritis patients: A cross-sectional study from Saudi Arabia. Clinical Rheumatology, 44(1), 45–52.https://doi.org/10.1007/s10067-024-06892-3
Chowdhury, T., Dutta, J., Noel, P., & Sharma, A. (2022). An overview on causes of nonadherence in the treat-ment of rheumatoid arthritis: Its effect on mortality and ways to improve adherence. Cureus, 14(4), e24520.https://doi.org/10.7759/cureus.24520
Curtis, J.R., Chen, L., Bharat, A., Yang, S., Patkar, N., & Safford, M. (2017). Adherence to combination DMARD therapy and treatment outcomes in rheumatoid arthritis: A longitudinal study of new and existing DMARD users. Rheumatology International, 37(6), 897–904.https://doi.org/10.1007/s00296-017-3661-5
Hashimoto, H., & Tanaka, Y. (2018). Disease activity and flare in early rheumatoid arthritis: Impact of medica-tion adherence. Modern Rheumatology, 28(4), 612–618.https://doi.org/10.1080/14397595.2017.1386145
Li, L., Zhang, S., Huang, Y., & Chen, X. (2017). Medication adherence has an impact on disease activity in rheumatoid arthritis: A systematic review and meta-analysis. Patient Preference and Adherence, 11, 1343–1356.https://doi.org/10.2147/PPA.S140457
Machin, A. J., Smith, T. O., & Hider, S. L. (2020). Depression and rheumatoid arthritis: A systematic review of the association and treatment implications. Rheumatology Advances in Practice, 4(1), rkaa012.https://doi.org/10.1093/rap/rkaa012
Mahran, R., El-Gohary, A., & Mohamed, N. (2021). Medication adherence in rheumatoid arthritis patients: Pre-dictors and outcomes in a Middle Eastern cohort. International Journal of Rheumatology, 2021, 1–8.https://doi.org/10.1155/2021/6654823
Matcham, F., Rayner, L., Steer, S., & Hotopf, M. (2013). The impact of rheumatoid arthritis on quality of life: A systematic review and meta-analysis. Arthritis Care & Research, 65(10), 1629–1637.https://doi.org/10.1002/acr.22018
Matcham, F., Norton, S., Scott, D.L., Steer, S., & Hotopf, M. (2016). Symptoms of depression and anxiety pre-dict treatment response and long-term physical health outcomes in rheumatoid arthritis: Secondary analysis of a randomized controlled trial. Arthritis Care & Research, 68(9), 1275–1282.https://doi.org/10.1002/acr.22811
Ouyang, J., Li, X., Chen, Y., & Wang, Y. (2025). Early menopause and rheumatoid arthritis disease activity: A prospective cohort study. Annals of the Rheumatic Diseases, 84(2), 210–217.https://doi.org/10.1136/ard-2024-226145
Radu, A.F., & Bungau, S.G. (2021). Management of rheumatoid arthritis: An overview. Cells, 10(11), 2857.https://doi.org/10.3390/cells10112857
Riyanto, A. (2020). Fundamentals of clinical and applied research methodology. Nuha Medika.
Sparks, J. A. (2019). Rheumatoid arthritis. Annals of Internal Medicine, 170(1), ITC1–ITC16.https://doi.org/10.7326/AITC201901010
Vidal, C., Gómez-Huelgas, R., Hernández, J.L., & Nolla, J.M. (2015). Obesity and rheumatoid arthritis: A new risk factor? Clinical Rheumatology, 34(4), 567–574.https://doi.org/10.1007/s10067-014-2772-6
Vrijens, B., De Geest, S., Hughes, D.A., Przemyslaw, K., Demonceau, J., Ruppar, T., ... & Urquhart, J. (2022). A new taxonomy for describing and defining adherence to medications. British Journal of Clinical Pharmacolo-gy, 73(5), 691–705.https://doi.org/10.1111/j.1365-2125.2012.04167.x
Çalışkan Uçkun, A., Yurdakul, F.G., & Bodur, H. (2019). Risk factors for poor medication adherence in rheuma-toid arthritis patients: A cross-sectional study. Turkish Journal of Physical Medicine and Rehabilitation, 65(4), 343–351.https://doi.org/10.5606/tftrd.2019.2820.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Putri Amanda Anggraini Harahap, Herlina Yani, Andre Budi
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
